Delivery Order SPE2DB20D1100-SPE2DB24FB7N4
- Not listed
- This federal contract award is for the delivery of INFANRIX DTAP SYRINGE 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,636.31, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on February 28, 2024, with a completion date of February 29, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of INFANRIX DTAP SYRINGE 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,825.00 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on May 6, 2022, with a completion date of May 9, 2022. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...
- This federal contract award, valued at $1,179.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the delivery of INFANRIX DTAP SYRINGE 0.5ML, a pharmaceutical product, with a completion date of September 9, 2024. The contract type is Delivery Order with a Firm Fixed Price pricing structure. This contract award is not associated with a set-aside designation. Amerisourcebergen Drug Corp is a major supplier of...
- This federal contract award, valued at $1,769.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4565804930 INFANRIX DTAP SYRINGE 0.5ML, with a completion date of September 16, 2024. This is a Firm Fixed Price Delivery Order contract, and there is no set-aside designation. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,949.00 firm-fixed-price delivery order contract covers the supply of INFANRIX DTAP SYRINGE 0.5ML medical products. The contract has an ultimate completion date of August 21, 2024. While the original solicitation was not provided, the contract appears to be part of a larger Indefinite Delivery Contract (IDC)...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide INFANRIX DTAP SYRINGE 0.5ML vaccines. This $1,204.90 contract has a period of performance through April 15, 2024. AmerisourceBergen Drug Corp is the prime contractor for this order, which is a child contract under a potential $999,999,999.00 indefinite delivery contract (IDC) the company holds with DLA to supply...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of INFANRIX DTAP SYRINGE 0.5ML. The contract has a ceiling value of $2,034.72 and is a Firm Fixed Price Delivery Order with a completion date of June 18, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This...
- This federal contract award is for the delivery of INFANRIX DTAP SYRINGE 0.5ML to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $1,332.30, was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has no set-aside designation, indicating open competition. The award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,091.60 firm fixed-price contract is for the supply of INFANRIX DTAP SYRINGE 0.5ML, which is a vaccine product. The contract has an ultimate completion date of March 27, 2025 and was awarded on March 26, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite...
- This is a $1,649.67 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of INFANRIX DTAP SYRINGE 0.5ML, a pharmaceutical product, with a completion date of June 27, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical and...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FB7N4Delivery Order
This federal contract award is for the delivery of INFANRIX DTAP SYRINGE 0.5ML to the Defense Logistics Agency (DLA), a defense agency. The $4,423.50 firm fixed-price contract was awarded on May 13, 2024 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract has an ultimate completion date of May 14, 2024 and is not a set-aside. Amerisourcebergen Drug Corp, through its Corporate Office Division, is a significant supplier of pharmaceuticals and medical supplies to federal agencies, particularly the Department of Defense and Department of Veterans Affairs. The company holds a $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical, as well as a smaller $750,000 contract with the Department of Justice Federal Bureau of Investigation, to provide a comprehensive range of medical products and prescription drugs to government facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 5/13/24 |